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In 1937, the foundation year of the Brazilian Institute for Tuberculosis Research, three ques-
tions  persisted in the researchers’ mind: “What is the real value of BCG? How to solve the
problem  of the chest register of large communities? When will we have a speciﬁc drug for
the  treatment of tuberculosis?” Along with this line of thought, the author presents a list of
the Institute’s main contributions, by pointing out the following topics: different diagnoses
between  pulmonary tuberculosis and pulmonary schistosomiasis; innocuity of iodine salts
in pulmonary tuberculosis; relative value of Weltmann and Takata-Ara’s reactions, and of
blood and lipase rates in bacillosis; the value of the bacteriologic diagnosis (method of precip-
itation, standardization of drug sensitivity tests; identiﬁcation of non-pathogenetic germs
not  only in the sputum but also in gastric Broncho-Alveolar Lavage, playing an important
role  in the infection tropics; probable protective role of BCG in tuberculin positive individ-
uals;  increase in awareness of the value of tuberculin; comparative studies of several types of
tuberculin; clinical and epidemiological importance of nontoxic drugs; tuberculin surveys in
Salvador and Feira de Santana cities; proposed classiﬁcation of clinical forms of pulmonary
tuberculosis;  increase in the value of selective miniature chest radiography; standardization
of  radiological shadows; and tests on the therapeutic value of the drugs. To SILVEIRA, IBIT’S
contribution  can be summarized in eight points: importance of bacteriology in the diagno-
sis  and therapeutic procedures; increase in the value of tuberculin tests; selective miniature
chest  radiography; possibility of replacing the hospital by an ambulatory care center; BCGvaccination; wide and general indispensability of a well-done and well-balanced therapeu-
tic  scheme; simpliﬁed treatment; progressive shortening of the treatment program; no over
optimism about the ﬁrst victories in the bacilli therapy.
veira  elucidated some clinical and pathologic features. Silveira
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n 1937, the year of establishment of IBIT, three questions per-
isted  in the investigators’ minds: (1) What is the true use for
he  BCG? (2) How to solve the problem of thoracic investigation
n  large crowds? (3) How to get a speciﬁc medication for tuber-
© 20ulosis?  The IBIT during its ﬁrst ﬁfty years, tried to answer
hese  questions.
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Belonging to a tropical country, the Institute began study-
ing  the correlation of tuberculosis with ascariasis,1 malaria,2
ﬁlariasis3 and schistosomiasis.4–9 About schistosomiasis, Sil-
sevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDquisa Clínica, Salvador, BA 40210-320, Brazil.
demonstrated that, in its lung location, it causes several
vascular disorders2 and a pneumonitis image.  The fact was
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corroborated by Shaw and Ghareb in Egypt, and Alves Meira
in  Sao Paulo.9 Knipping, included the “Silveira’s pulmonary
bilharziosis”, while discussing the cor pulmonale risk factors.
Development  of  therapy  for  tuberculosis
Before the modern armamentarium of chemotherapy, the IBIT
tested the importance of some substances although without
bacteriostatic or bactericidal effects as an adjunct of therapy
as  no effective drugs were  available at that moment. We  cite
as  an example the work of Silveira and Silveira and Costa on
salts  of calcium, iodine,10 copper and gold.11,12 Silveira said:
“based on carefully performed clinical histories with docu-
mented  radiological and laboratory tests, we have been able to
heal many  people, as denounced in some published papers”.13
From the tentative chemotherapy insecure IBIT worked
on  the collapsotherapy and artiﬁcial pneumothorax, meth-
ods  of use in Bahia, at that time. Codes and Sandoval14 began
the  practice of phrenicectomy, Macedo Costa devoted himself
to  the study of pleural adhesions,15 and Bridges16 embarked
on  the thoracoplasty, Cardoso and Góes17 in the pulmonary
resection.
Rist  et al. studied clinically 2nd line drugs in collabora-
tion research protocols. These studies made it possible for
IBIT  to use experimentally several drugs (isoxil, ciclocerina,
ethionamide, pyrazinamide, ethambutol and rifampicin) and
its  application in economic simpliﬁed schemes and combina-
tions.
This  paper from Silveira et al.18 on intermittent chemother-
apy  of tuberculosis is noteworthy. These authors, based on
an  experimental model of GRUMBACH investigated: (1) the
importance  of a triple daily regimen for one month, with the
combination  Isoniazid (INH), Streptomycin and Ethambutol
(EMB);  (2) this previous regimen forwarded by the intermit-
tent  use of the combination of INH-EMB, three times per week,
using  double and normal dosage, and (3) the intermittent
action of INH + EMB  three times per week, daily for one month
without  streptomycin. In 1968, the authors were  encouraged
by  the results with the combination EMB  + DAT + Ka in patients
with  persistent positive cavitary lesions, some of them with
history  of collapsotherapy, resistant to 1st and 2nd line drugs,
considered  irrecoverable after prolonged hospitalization (aver-
age of four years), so Silveira, recommended this intervention
to  diminish prolonged hospitalizations.19
Some of the pharmaceutical companies have asked the
IBIT  to test new proposed drugs. Interested in a sub-
stance able to replace the para-amino-salicylic (PAS), Silveira
et  al.20 used a thiurea derivative, known for its tubercu-
lostatic action [diisoamylhydroxythiocarbanilide (Isoxyl)].21
They used the product in three patients with previous his-
tory  of prolonged treatment, resistant to traditional drugs.
Two  patients did not respond but the third one the smear
became negative. However, this latter case had undergone
thoracoplasty during treatment and the results were consid-
ered  doubtful, the drug however was  considered with good
tolerance.
Aiming  to determine the power of this tuberculostatic drug,
the  authors selected four patients hospitalized in the Tho-
rax  Hospital (presently Hospital Santo Amaro) and twelve 1 3;1  7(2):205–210
from the of IBIT outpatient clinic. Of the latter, one died
early  during the trial, one died during treatment, and six
left  the trial after the ﬁrst prescription. Only eight patients
completed the treatment. In all cases, after a sometime,
the drug under test (Isoxyl) was  required to be associated
with other drugs, since, despite producing some effect, the
Isoxyl  did not cure the disease. The conclusion was  that
the  drug subjected to experimental conditions was  com-
pletely  unfavorable for patients with long history of treatment
with  very advanced lung processes and releasing resistant
bacilli  to all classic drugs. In a single patient, previously
untreated, the result was much  better, not achieving a com-
plete  success because the drug was ﬁrst used alone in
doses  considered subsequently insufﬁcient. No intolerance
was  registered for any case. Conclusions were  ﬁrstly, it was
clear  that the result is more  effective in naïve patients.
Secondly, the use of DAT demonstrates that the drug was
unable  to cure by using alone. Thirdly, association with strong
tuberculostatic drugs seems to reinforce the action of the
drug.
Tuberculosis  diagnosis  trials
From early 30s to 40s IBIT developed research on blood glucose
reactions,22 while the value of Welmann23,24 and Takata-
Arada25 reactions conducted research on precipitation in
double  diffusion Agar,26 hematic levels,27 and erythrocyte sed-
imentation  rate24 in patients with pulmonary tuberculosis.
Darzins contributed greatly to the success of these ﬁndings.28
Thanks to Darzins IBIT developed the method of agitation /
precipitation,29 and standardized the drug sensitivity tests (at
a  time when these were virtually unknown in Brazil), where
he  also discovered several species of the genus Mycobac-
terium, and newly described the Mycobacterium gyae30 and
other  nonpathogenic bacteria isolated from sputum, bronchial
and  gastric lavages.31
Other foreign scientists and technicians who worked in
IBIT  contributed enormously in the basis of the institution
to  greater awareness of the disease. Among these scientists
we  can highlight Canetti (France), Pantzer (Romania), Cetran-
golo  (Argentina), Reutgen (Germany), Bravo (Spain), Gossner
(Germany), Lorian (United States) and Hilscher (Germany),
and  Rist et al. Among the technicians it can be mentioned
that Elizabeth Gheno, who contributed to the organization
of  the Department of Pathology and Hans Geissler who  con-
tributed  to the creation and organization of the Department
of  Scientiﬁc Documentation. Canetti established standards for
the resistance evaluation of M.  tuberculosis to antituberculosis
drugs. To him is credited the knowledge of the bacterial ﬂora
of  tuberculous lesions and the basic conditions for the appli-
cation  of antituberculosis chemotherapy in Brazil. To Canetti,
Grosset  and Grumbach we  owe the proportional sensitivity
test  and IBIT was  the ﬁrst to use this test in northern and
northeastern Brazil.32
Due to its high concept at that time in performing drug sen-
sitivity  tests, the IBIT was  also looked upon to perform surveys
of  industrial interest. It was  the case sulfate-reducing bacte-
ria  isolation and the bactericidal action of certain chemicals
by  such bacteria, research of interest in this case by Petróleo
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Table 1 – Prevalence of resistance to ethambutol and rifampicin of Mycobacterium tuberculosis isolates from 1970 to 1976
at the Instituto Brasileiro para a Investigac¸ão da Tuberculose.
Year Number examined Ethambutol Rifampicin EMB + RMP
Resistant % Resistant % Resistant %
1970 597 11 1.8 3 0.5 2 0.3
1971 809 14 1.7 10 1.2 5 0.6
1972 686 11 1.5 6 0.8 9 1.3
1973 829 9 1.0 17 2.0 11 1.4
1974 750 10 1.3 11 1.4 9 1.2
1975 600 16 2.6 7 1.4 10 1.6
0 
B
a
t
e
t
t
T
T
t
i
t
i
a
s
t
t
a
a
t
r
c
a
h
i
t
i
t
s
a
s
ﬁ
n
a
b
o
b
t
p
t
t
i
o1976 290 6 2.
BEM, ethambutol; RMP, rifampicin.
rasileiro SA (PETROBRAS).33 In many  opportunities IBIT was
sked  to clarify doubts and clarify issues related to diagnosis,
herapy and prophylaxis of tuberculosis as well as opine on
pidemiological issues. An example of this is the survey on
he  resistance of M.  tuberculosis against EMB and RMP, during
he  years of 1970 to 1976 (Table 1).
he  use  of  BCG
he papers of Silveira34–38 and Silveira and Medeiros39–42 on
he  protective power of BCG in allergic patients are of great
mportance. The research aimed to answer the following ques-
ions:  (1) What should be done with the high percentage of
nfected  individuals without active tuberculous lesion, which
re  forced to live with smear positive tuberculosis? (2) What
hould  be done with the family members of a patient with
uberculosis, when its isolation is impossible and a fatal infec-
ion  is present in an environment with several exposed? In
ddition,  for those infected, what should be done? Silveira
nd  Medeiros analyzed the results obtained with the observa-
ion  of 57 allergic patients, vaccinated with BCG orally in doses
anging  from 0.10 to 0.50 g. The research led to the following
onclusions: (1) BCG is completely innocuous for individuals
lready infected, even when living in an environment with
igh  probability of infection and reinfection. (2) In addition to
nnocuous, the prospect, in such individuals, of their protec-
ive  role. (3) After repeated BCG vaccination, there is a possible
ncrease  of the immunity of primo-infected. (4) Days after
he  use of the oral vaccine, there is exaltation of cutaneous
ensitivity to tuberculin, followed by pronounced attenuation
nd  even complete extinction of allergy. (5) The loss of allergy
eems  to depend on genetic component. The BCG was  bene-
cial  not only for the newborns but also for those who have
ot  been contaminated by M.  tuberculosis, and even in those
lready  infected, “allergic”. BCG may  have shown apprecia-
le  protective power against successive re-infections. The data
btained were limited in time and space, and if the application
y  mass vaccination of allergic is not authorized, it requires
hat  these investigations be repeated on a larger scale because,
roven  conclusively the existence of the protective power of
he  BCG for allergy sufferers, will have taken a step toward the
uberculosis  prophylaxis, especially in countries with a high
ncidence  rate of this disease, where there is a high percentage
f  allergic exposed to infection.10 3.4 5 1.7
Tuberculin  studies
In particular BCG and tuberculin diagnosis, owe much  to the
IBIT  studies of Silveira, Durval, Freitas and Medeiros.43–45 Con-
ﬁrming  previous observation,46 Silveira said the fact that large
and  repeated doses of BCG do not result positive response in
some  newborns, even when employing the dermal one, seems
to  be linked to a familial predisposition.47 Silveira vaccinated
those with positive tuberculin, the sick and apparently healthy
with  good results; “with this, the IBIT, Stela Medeiros and I, we
entered the École Brésilienne of BCG, so expected, especially
for  the French professors and researchers Drs. Max  Fourestier
and  Gernez Rieux” wrote Silveira once. IBIT removed several
“dogmas”47 that prevented the wide application of BCG: the
obsession  of allergy, the failure of the oral method, the dan-
gers  of vaccination of perennial allergic and immunizing the
primary  infection. The scope of this achievement is of utmost
importance for developing countries, where there are masses
of  people uneducated, lack of hospital beds and lack of quali-
ﬁed  technicians.
Medeiros42 published an important work on exposure
to infection, infection in children, epidemiological surveys,
comparison between different known tuberculin prepara-
tions,  including raw and puriﬁed ones, and disappearance
of reaction in certain circumstances. The IBIT conducted a
comparative  study of tuberculin BCG2 and BCG3 (provided by
Assis) and tuberculin puriﬁed from Germany, Denmark and
France.  “If, at ﬁrst glance, the tuberculin puriﬁed, should be
preferred  – Silveira says – and in fact increasingly – we  must
not  forget that the old tuberculin of Koch (especially if pre-
pared  in synthetic media) continues to offer regularity good
results  and an accuracy of speciﬁcity that cannot be ignored”.
The  investigations carried out in IBIT demonstrated that the
use  of tuberculin in a dilution of 1/10 (10 mg  raw tuberculin),
plus weaker dilutions, would discover about 10% more  aller-
gic.  The veriﬁcation of the Saye-Willis phenomenon, caused by
mouth, adds 12% positivity. “Testing with weaker tuberculin
concentrations (1/1000 or 1/100), as has been widely practiced,
is  missing many  already infected as false non-allergic and
therefore  true allergy ones have been widely vaccinated”.
Durval44 showed that among those who  lost their tuber-
culin  allergy there is predominance of young individuals less
than  20 years of age. Contrary to the widespread belief, Sil-
veira  noted that this loss is made in similar proportions
in both males and females, being more  pronounced when
i s . 2 0208  b r a z j i n f e c t d 
administering the BCG. Regarding ethnicity, both in the vac-
cinated  as non vaccinated, the loss among African descents
was  much  more  pronounced (50%). When the loss of allergy
was  more  difﬁcult when initial allergic reactivity was greater.
This  tendency was  greater in those vaccinated with BCG, and
in  those this ﬁgure could raise to 100% of allergy loss. Rosem-
berg  and Silveira48,49 demonstrated that, contrary to what was
sustained,  the repeated use of BCG does not cause allergy.
Rather,  it attenuates. This desensitization is very sharp and
can  reach total extinction. This loss of allergy is beneﬁcial or
harmful  to the patient? Trying to ﬁnd the answer, Silveira,50
after two years of accurate observation, found in 37 vacci-
nated,  only 3 patients with nonspeciﬁc pulmonary processes,
so  91% of cases without any clinical signs or radiological or
laboratory  abnormalities. Among the controls, the percentage
was  slightly lower, i.e., 88%. The conclusion was  the recog-
nition  of the existence of re-infection in individuals being
labeled  as a primary infection. In the opinion of Silveira the
existence  of primary forms of infection in adults should be
rare  and its labeling much  more  cautious.
In 1939, under the direction of Silveira,51 a survey was con-
ducted  in the city of Salvador tuberculin in boarding schools
for  poor children and Penitentiary (largely inmates in the state,
young  adults). Hygiene conditions were  equivalent, as well as
food and labor regime. Three dilutions (1/25,000, 1/100 and
1/10)  were  used. Hyper-reactors were  considered as those reac-
tors to the ﬁrst dilution; medium-reactor those positive to the
second  dilution; hypo-ergics, as those positive only to the third
dilution. ASSIS demonstrated the existence of individuals who
maintained their allergy below the ordinary (infra-tuberculinic
allergy of Assis),52 which makes it necessary to awaken the
allergy  with a dose of BCG to repeat after the intradermal to
1/10.  Strictly speaking, only people who respond negatively
should  be considered not allergic.
The purpose of tuberculin survey was  to discover those
not  allergic, so targeted to BCG vaccination. In Brazil, ﬁrst
Assis52,53 then Silveira38 and Silveira and Medeiros41 proved
that BCG does not affect the allergic and therefore recom-
mended not “molesting” the individuals with the completion
of  several tests. We  vaccinate indifferently performing “mass
vaccination”.  Race; inﬂuence of several physiological states
such  as pregnancy, hormonal and nutritional factors; and
even  geographic variations may  modify the allergic state. Even
saprophytic  bacilli can cause positive reactions. Such factors
exist,  are rare and have no inﬂuence on the tuberculin overall
status,  and its epidemiological interpretation. Two thousand
one  hundred thirty-ﬁve people were  tested, of these, 87.6%
were  reactors and 12.4% non-reactors. Of those non-allergic,
26.1%  were falsely non-allergic. The percentage of reactors
increased rapidly after 5 years of age. The peak was  observed
in  ages from 15 to 20, and then a decline was  observed with
advancing age. That has not stopped people with advanced
age  to present strong reactions. Between 80 and 90 years of age,
33 people were  found positive, ofwhich 14 were  hyper-ergics,
18  normal-ergics and only one hypo-ergic. The reactions were
stronger  in African descents. Among the false reactors pre-
dominant  white race (21 white and 8 African descents). Among
men,  there was  a predominance of those hyper-ergics and
among  women  the predominance were normal respoinseve
or  hypo-ergics. 1 3;1  7(2):205–210
Studies  on  radiology  of  tuberculosis
In Brazil, the forms of primary infection and re-infection are
common.  The forms of re-infection are rare and exceptional
circumstances and when they arise, they often replicate from
the  primary infection, so it is not always easy to distinguish.
Santos54,55 has contributed to many  aspects of radiological
investigation in IBIT.
The  work of Costa56 about radiological topography is note-
worthy:  “Taking as its point of reference 6th and 9th ribs
and  drawing two horizontal lines across the the chest, I have
divided  the lung ﬁelds in three areas: upper, middle and lower.
These  three zones are in turn subdivided into two regions
–  internal and external – on a vertical line starting from
the  middle half of the clavicle of the diaphragm homolo-
gous”. Shortly after, Silveira had proposed systematization of
pleuropulmonary images based on three modalities: images
condensation (with the types miliary, nodular, nummular,
linceolar, linear, fascicular and reticular), refractive images
(with  the types emphysema and pneumo) and mixed images
(with  spongiloid types, ring and air-ﬂuid). Of unquestionable
value to the time of its publication is the experience of Costa
tomography of lung. Costa recommended the necessity of
stratigraphy:  (1) In search of the tuberculosis with cavities
(outline contour, volume and depth). (2) The elucidation of
the  possible existence of cavity before thickening, or rather
of  a pleural effusion. (3) In choosing the best surgical option,
considering the extent of resection of the ribs and number of
operative  sessions, and (4) control of the therapeutic result,
face  closure or not the cavity.57
Among the reasons that led to the abandonment of
roentgenphotography58,59 in epidemiological surveys, was  the
ﬁnding  of potential doubtful shadows, outside the conditions
of  an open tuberculosis, easy disclosure by bacteriological. In
1951, Silveira,41 in the 5th National Congress of Tuberculosis,
presented a proposal to standardize the patients diagnosis
with  thoracic shadow, and their medical and social signiﬁ-
cance.
Studies  on  sputum  smear  baciloscopy
Oliva60 comparing culture results with those obtained by
direct  microscopy concluded that in about 30% of cases the
culture  is positive, while the smear is negative. The same
author  used the antigen for testing the reaction of precip-
itation  in double diffusion in agar.61 Machado,26 using this
antigen  in 43 patients with tuberculosis obtained 18 positive
results  (44%), 11 undetermined and 13 negative ones. When
the  discordant results were  tested again, 60% positivity was
achieved.
The  appreciation of the bacteriological examinations was
an  important contribution. Silveira37 summarizes this contri-
bution  on ﬁve items: (1) Suppression of strong acids and alkalis
in  the preparation of material for culture and inoculation. (2)
Isolation  of mycobacteria non-pathogenic to guinea pigs with
morphological and cultural properties identical to M.  tuberculo-
sis.  (3) Possibility of higher frequency non-pathogenic bacteria
in  the tropics. (4) Attenuation of germs by chemotherapy, or
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y the elimination of BCG (tuberculin-positive individuals). (5)
he need for a detailed study on the frequency and nature
f  non-pathogenic germs, not only to improve the quality of
acteriological  diagnosis but also to know more  accurately the
iology  of M.  tuberculosis.
onclusion
e  quote Silveira who  summarized the participation of IBIT in
ight points: (1) the fundamental importance of bacteriology in
he diagnosis and therapeutic management of the patient with
uberculosis,  (2) enhancement of the tuberculin test for per-
ecting  the knowledge of the immune status of the patient; (3)
elective roentgenphotography instead of widespread use of
he  Abreugraphy (4) ability to replace the treatment from hos-
ital  based to out-patient clinic, and the new results are rich
nd  secure, (5) extensive and widespread vaccination with-
ut  prior tuberculin tests, (6) Indispensability of a therapeutic
chema well-conducted and well-balanced, based on carefully
elected  drugs; (7) progressive shortening of the treatment
rogram,  and (8) complete rejection of victory without new
esources  and means to combat the disease. “Such results”,
e  said, “have not given us, is truth, enough originality to
rofoundly  alter the evolution of scientiﬁc thought. We  were
ictims  of our poverty, without adequate human resources
nd  equipment, working on our own, with pour and uncertain
upport  of ofﬁcial aid, never managed to create the adequate
echnical and functional means indispensable to mount the
rogram  dreamed”.
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